HeartLung AI

2450 Holcombe Blvd TMC Innovations Houston, TX 77021  All United States companies → — Founded 2019
Imaging AI Specialist Specialty-Focused AI
Bootstrapped

Products

AI-CVD
HeartLung AI
Cardiology AI

See all 1 product →

About HeartLung AI

HeartLung AI is a healthcare AI company that specializes in AI-powered preventive CT imaging. Their flagship product, AI-CVD, analyzes routine CT scans to provide comprehensive health insights beyond traditional calcium scoring and lung screening. This includes detailed reports on coronary calcification, aortic calcification, epicardial fat, cardiac chambers, aorta and pulmonary artery size, lung low attenuation index (LAI), lung high attenuation index (HAI), liver fat, muscle and visceral fat, and bone density.

The platform aims to unlock hidden intelligence within every coronary calcium scan, enabling earlier detection of cardiovascular disease and lung cancer. It provides physicians with AI biomarkers, annotated images, clear quantitative clinical reports, DICOM previews, longitudinal tracking capabilities, and risk prediction tools based on CT-derived imaging biomarkers. HeartLung AI’s solutions are supported by a team of world-renowned researchers, physicians, and pioneers in cardiovascular imaging.

Focus Areas

cardiovascular disease lung cancer emphysema/COPD osteoporosis myosteatosis fatty liver disease early disease detection preventive imaging AI-powered quantitative imaging

Business Intelligence

Technologycloud-enabled framework, deep learning models

What Physicians Need to Know

AI-Powered Early Detection
Specializes in AI-powered early detection of cardiovascular disease and lung cancer using routine CT scans.
Comprehensive Health Insights from One Scan
Offers a single scan to generate reports on coronary calcification, aortic calcification, epicardial fat, cardiac chambers, aorta & PA size, lung LAI, lung HAI, liver fat, muscle & visceral fat, and bone density.
Beyond Calcium Scoring
Unlocks hidden intelligence in every coronary calcium scan, providing more comprehensive insights than traditional calcium scoring.
AI Biomarkers
Extracts cardiovascular biomarkers from routine CT scans, providing quantitative, physician-facing measurements.
Longitudinal Tracking
Enables monitoring of patient progress over time.
Risk Prediction
Quantifies CT-derived imaging biomarkers to support cardiovascular risk assessment.
Supported by World-Renowned Experts
Backed by world-renowned researchers, physicians, and pioneers in cardiovascular imaging.
Patented Technology
Utilizes patented and patent-pending technologies for its AI solutions.
Physician Tip

Physicians can leverage HeartLung AI's solutions to gain comprehensive health insights from a single CT scan, enabling earlier detection of cardiovascular disease and lung cancer. The AI-CVD platform provides detailed reports on various biomarkers, including coronary and aortic calcification, cardiac chamber volumes, lung density, liver fat, muscle & visceral fat, and bone density. This allows for enhanced risk prediction, longitudinal tracking of patient progress, and the ability to unlock hidden intelligence from existing scans, potentially leading to improved patient outcomes and more proactive preventive care. The platform is designed to integrate with existing workflows and offers clear, quantitative, physician-facing measurements.

Products by HeartLung AI

1 product in the directory

AI-CVD
HeartLung AI
Cardiology AI

Videos

News, demos, and interviews about HeartLung AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for HeartLung AI →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

HeartLung AI's technology helps detect coronary calcification, aortic calcification, epicardial fat, cardiac chamber abnormalities, and aorta and pulmonary artery size issues. It also identifies lung low attenuation index (LAI) and high attenuation index (HAI), which are relevant for lung conditions.
Beyond cardiovascular and pulmonary conditions, HeartLung AI assists in early detection by analyzing liver fat, muscle and visceral fat, and bone density from CT scans.
HeartLung AI's platform can analyze data from coronary artery calcium scans, LDCT lung cancer screening scans, lung diagnostic scans, and coronary CT angiography scans.
HeartLung AI provides clinical reports with clear, quantitative, physician-facing measurements, annotated images showing AI segmentation and overlays, and DICOM previews for interactive viewing and comparison.
Yes, HeartLung AI offers longitudinal tracking to monitor patient progress over time for the various conditions it assesses.
HeartLung AI supports cardiovascular risk assessment by quantifying CT-derived imaging biomarkers that may aid in risk evaluation.
The AI-CVD Bundle includes analyses for coronary calcification, aortic calcification, epicardial fat, cardiac chambers, aorta and PA size, lung LAI, lung HAI, liver fat, muscle and visceral fat, and bone density.

Related Companies

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

Medtronic is a global leader in healthcare technology, developing and manufacturing a vast array of medical devices and therapies. The company’s mission is to alleviate pain, restore health, and extend life for people with chronic conditions worldwide. Medtronic operates in over 150 countries, offering solutions across four main business units: Cardiovascular, Neuroscience, Medical Surgical, and […]

Philips Medical Systems Nederland B.V. is a key entity within Royal Philips, a leading global health technology company. The company focuses on improving people’s health and well-being through meaningful innovation, leveraging advanced technology and deep clinical and consumer insights to deliver integrated solutions. [6, 29] For physicians, this translates into a commitment to developing AI-enabled […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.